Nevada RNformation - December 2021
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Page 4 • <strong>Nevada</strong> <strong>RNformation</strong> <strong>December</strong> <strong>2021</strong>, January, February 2022<br />
NNA is excited to provide our RNF readers with this<br />
FREE CEU course!<br />
Authored by: Tracey Long PhD, MS, MSN, RN,<br />
APRN-BC, CDE, CNE, CHUC, COI, CCRN<br />
NNA Course #001 Polypharmacy Problems and<br />
Solutions<br />
Outline<br />
Section 1: The Problems of Polypharmacy<br />
Section 2: Adverse Effects of Overmedication<br />
Risks Overview<br />
Risk for Falls<br />
Section 3: Pharmacokinetics<br />
Absorption<br />
Distribution<br />
Metabolism<br />
Excretion<br />
Other Factors<br />
Section 4: Screening Strategies<br />
Beers Criteria<br />
STOPP/START<br />
The ARMOR Tool<br />
Section 5: Improving Medication Management<br />
Reducing Inappropriate Prescribing<br />
Decreasing Polypharmacy<br />
Avoiding Adverse Events and Reactions<br />
Section 6: Implications for Healthcare Professionals<br />
Section 7: Resources and References<br />
Section 8: Post-Test<br />
Polypharmacy: Problems and Solutions<br />
(Image Source: wiki commons images url:<br />
https://www.dreamstime.com/stock-photooverflowing-pillbox-closeup-image25488840)<br />
1.0 contact hours<br />
Author: Tracey Long PhD, MS, MSN, RN, APRN-BC,<br />
CDE, CNE, CHUC, COI, CCRN<br />
Course Summary: This course discusses the<br />
problems of polypharmacy, especially seen in the<br />
elderly. Pharmacodynamics will be explained in context<br />
to the aging body. It includes an introduction to<br />
Beer’s criteria, which is used to identify inappropriate<br />
medications for older adults. Measures to improve<br />
safe medication management and adherence will be<br />
discussed.<br />
Accreditation<br />
ANCC<br />
NNA<br />
Course Objectives<br />
When you finish this course, you will be able to:<br />
• Identify the problem of polypharmacy and<br />
summarize the risks of multiple medications.<br />
• Distinguish between pharmacokinetics and<br />
pharmacodynamics.<br />
• Explain Beers criteria and additional screening<br />
strategies to identify inappropriate medications<br />
for older adults.<br />
• Identify adverse results of polypharmacy.<br />
• List ways of improving medication management<br />
and avoiding polypharmacy.<br />
(Image Source: https://jeffreysterlingmd.files.<br />
wordpress.com/2016/02/medmngt.jpg)<br />
Introduction Case Scenario<br />
Walter, 78-year-old Caucasian male didn’t sound<br />
like himself on the phone while visiting with his son.<br />
As a widow he lives alone after raising his five children<br />
with his wife. In his retirement years he generally<br />
sits home watching TV and reading. His medical<br />
conditions include COPD, diabetes, neuropathy,<br />
hypertension, hypothyroidism, hyperlipidemia, obesity,<br />
and depression. He receives medications for each<br />
of these diseases in addition to over-the-counter<br />
vitamin supplements and herbal remedies a friend<br />
told him about, which total over 12 medications<br />
daily. His primary care provider (PCP) recently added<br />
a new medication for hypertension. In addition to<br />
his PCP, he sees a nephrologist, a cardiologist, and a<br />
pulmonologist. As his vision has worsened so has his<br />
memory of which medications he has already taken<br />
for the day. While talking to his son, the son noticed<br />
his father’s speech was slurred and he couldn’t stay<br />
up with the conversation. Later after work, the son<br />
drove to his father’s home and brought him to the<br />
emergency department at the local hospital. Hours<br />
later in the emergency department, and after multiple<br />
tests, it was determined he had taken too many<br />
medications over the past week and had induced<br />
delirium. Unfortunately, this scenario is all too<br />
common in the United States, especially in the geriatric<br />
population. Nurses need to be aware of the dangers of<br />
polypharmacy, the need for medication reconciliation<br />
at each visit, and proper patient education regarding<br />
medication management.<br />
Section 1: The Problems of Polypharmacy<br />
The concurrent use of several drugs, defined as<br />
polypharmacy, is a serious and often fatal issue.<br />
Polypharmacy is the use of five or more daily<br />
medications, including over-the-counter (OTC)<br />
medications, dietary supplements, and herbal<br />
remedies. Polypharmacy includes prescribing<br />
more medication than is clinically indicated, using<br />
inappropriate medications, and using the correct<br />
medication for an inappropriate length of time<br />
(Masnoon, et al, 2017; Pazan, et al, <strong>2021</strong>, AHRQ, 2015).<br />
Research shows polypharmcy of five or more drugs<br />
creates more potential adverse drug reactions (ADRs),<br />
also called adverse drug effects, as the medications<br />
interact with each other. Increased complications from<br />
comorbidities also impact the combination of various<br />
medications that each is each is trying to treat (AHRQ,<br />
2015; Sirois, et al, 2017). Other challenges include<br />
medical illiteracy, which may lead to nonadherence to<br />
the treatment regimen and prescription instructions,<br />
which may become more confusing to understand<br />
as each medication may have a different schedule.<br />
Medication management is an even greater challenge<br />
for the older adult due to decreasing vision and<br />
dexterity, comorbid conditions, often multiple<br />
caregivers and physicians involved, barriers to financial<br />
ability to pay for medications, nonadherence, declining<br />
metabolism and often memory decline. It is estimated<br />
that nearly half of older adults are taking one or more<br />
mediations that are not clinically necessary. More than<br />
90% of those 65 or older use at least one medication<br />
per week, 58% take five or more, and 12% use ten or<br />
more (Sirois, et al, 2019). Medication errors cause 10-<br />
30% of all hospitalizations annually in older patients<br />
(Parameswaran, 2016). Not only does polypharmacy<br />
create preventable healthcare costs, but significantly<br />
increases morbidity and mortality. It is estimated almost<br />
one third of older home health care patients are taking<br />
a medication that is considered inappropriate for older<br />
people (Cadenas, et al, <strong>2021</strong>).<br />
Home medication management systems range<br />
from the careful and methodical to the random<br />
and arbitrary. Elders who have difficulty opening<br />
medication bottles may utilize the “candy dish”<br />
method—dumping multiple medications into one<br />
bowl and fishing out the appropriate medication at the<br />
scheduled time. Some older adults store medications in<br />
shopping bags or shoeboxes while others carefully fill<br />
medication dividers weeks in advance. As the number<br />
of older adults increase, health professionals need to<br />
spend more time evaluating medication management<br />
in the home setting.<br />
The rate of growth in the number and proportion<br />
of older adults is unprecedented in the history of the<br />
United States. Two factors—longer life spans and the<br />
large cohort of aging baby boomers—will combine to<br />
double the population aged 65 and older in the next<br />
twenty-five years. By 2050 the population of age 65<br />
and older is estimated jump to 16% compared to the<br />
9% in 2020 (CDC, 2020). Globally the proportion of<br />
elderly adults is 10.5% and is projected to rise to 1.5<br />
billion people aged 65 and older (CDC, 2020). Proper<br />
use of medications is critical to proper and costeffective<br />
chronic disease management.<br />
Improved medical care and prevention efforts have<br />
contributed to dramatic increases in life expectancy<br />
in the United States over the past century. These<br />
factors have caused a major shift in the leading<br />
causes of death, from infectious diseases and acute<br />
illnesses to chronic diseases and degenerative<br />
illnesses. The incidence of chronic disease increases<br />
with advancing age, causing Medicare expenditures<br />
to rise proportionally. Currently, about 92% of older<br />
Americans are living with at least one chronic condition<br />
and 77% suffer from at least two diseases. (NCOA,<br />
2016). Elders who have developed multiple chronic<br />
diseases will therefore be at greater risk of being<br />
prescribed additional medicine as part of the treatment.<br />
The cost of providing healthcare for an older<br />
American is three to five times greater than the cost<br />
for someone younger than 65. By 2030 the nation’s<br />
healthcare spending is projected to increase by 33%<br />
(CMS, 2019). A large portion of medical expense is<br />
attributable to medication-related problems, which cost<br />
the United States 300,000 lives and $3.6 a year (CDC,<br />
<strong>2021</strong>). The elderly are at risk because of their high rate<br />
of medication use.<br />
Polypharmacy significantly increases the chance for<br />
medication non-adherence, medication errors, and<br />
drug-drug, drug-food, and drug-disease interactions.<br />
The risk for adverse drug reactions (ADRs) increases as<br />
the number of medications increases. The older adult<br />
who has cognitive impairment, who is living alone, or<br />
who is seeing multiple prescribers, is especially at risk.<br />
In addition, normal changes of aging alter the effect of<br />
medications, so that medications that are appropriate<br />
for younger people may be contraindicated in older<br />
adults due to a lower muscle mass, slower renal<br />
clearance and intestinal absorption.<br />
In the United States, nearly 30% of all hospital<br />
admissions are older adults who have not taken their<br />
medications properly. The classes of drugs most<br />
commonly associated with adverse drug reactions in<br />
older adults include diuretics, warfarin, nonsteroidal<br />
anti-inflammatory drugs (NSAIDs), selective serotonin<br />
reuptake inhibitors (SSRIs), beta blockers, and<br />
angiotensin-converting enzyme inhibitors (ACEI)<br />
(Christensen, et al, 2019; Neuman, et al, 2015).